Stock Market & Financial Investment News

News Breaks March 18, 2013 08:32 EDT DNDN Dendreon announces securities class action settlement Dendreon has reached an agreement in principle to settle the securities class action litigation pending against it in the United States District Court for the Western District of Washington. Upon final approval, the settlement will resolve the claims asserted against all defendants in the previously disclosed putative securities class action. The lawsuit is currently pending against the Company and three current and former executive officers. In the lawsuit, captioned In re Dendreon Corporation Class Action Litigation, Master Docket No. C 11-1291 JLR., an investor, purporting to represent a class consisting of persons who purchased Dendreon common stock between April 29, 2010 and August 3, 2011, sought unspecified damages from Dendreon and three current and former officers of the Company for allegedly false or misleading statements concerning the company, its finances, business operations and prospects with a focus on the market launch of PROVENGE and related forecasts concerning physician adoption, and revenue from sales of PROVENGE. The terms agreed upon by the parties contemplates a settlement payment of $40M, $38M of which will be funded by Dendreon’s insurers. Dendreon and the individual defendants continue to deny that any statements they made were false or misleading. News For DNDN From The Last 14 Days Check below for free stories on DNDN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 10, 2013 10:00 EDT DNDN On The Fly: Analyst Downgrade Summary Subscribe for More Information 09:38 EDT DNDN Active equity option families trading Subscribe for More Information 09:21 EDT DNDN On The Fly: Pre-market Movers Subscribe for More Information 07:55 EDT DNDN Dendreon may generate near-term trading opportunity, says RW Baird Subscribe for More Information 07:44 EDT DNDN Dendreon price target lowered to $1 from $5 at BofA/Merrill Subscribe for More Information 07:40 EDT DNDN Dendreon price target lowered to $6.50 from $9 at Bernstein Subscribe for More Information 05:51 EDT DNDN Dendreon downgraded to Sell from Neutral at Citigroup Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.